Cargando…

Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?

Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized f...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Graciliana, Sousa, Carla, Silva, Luís R., Pinto, Eugénia, Andrade, Paula B., Bernardo, João, Mouga, Teresa, Valentão, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271118/
https://www.ncbi.nlm.nih.gov/pubmed/22319609
http://dx.doi.org/10.1371/journal.pone.0031145
_version_ 1782222659619127296
author Lopes, Graciliana
Sousa, Carla
Silva, Luís R.
Pinto, Eugénia
Andrade, Paula B.
Bernardo, João
Mouga, Teresa
Valentão, Patrícia
author_facet Lopes, Graciliana
Sousa, Carla
Silva, Luís R.
Pinto, Eugénia
Andrade, Paula B.
Bernardo, João
Mouga, Teresa
Valentão, Patrícia
author_sort Lopes, Graciliana
collection PubMed
description Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized for their biological capacity. This study represents the first research on the antibacterial, antifungal, anti-inflammatory and antioxidant activity of phlorotannins purified extracts, which were obtained from ten dominant brown seaweeds of the occidental Portuguese coast. Phlorotannins content was determined by the specific dimethoxybenzaldehyde (DMBA) method and a yield between 75 and 969 mg/Kg phloroglucinol units (dry matter) was obtained. Fucus spiralis ranked first, followed by three Cystoseira species. The anti-inflammatory potential of the purified extracts was assessed via inhibitory effect on nitric oxide (NO) production by lipopolysaccharide-stimulated RAW 264.7 macrophage cells, Cystoseira tamariscifolia being the one showing promising activity for the treatment of inflammation. NO scavenging ability was also addressed in cell free systems, F. spiralis being the species with highest capacity. The antimicrobial potential of the extracts was checked against five Gram-positive and four Gram-negative bacteria and three fungi strains, that commonly colonize skin and mucosa and are responsible for food contamination. The different extracts were more effective against Gram-positive bacteria, Staphylococcus epidermidis being the most susceptible species. Concerning antifungal activity, Trichophyton rubrum was the most sensitive species. Although the molecular mechanisms underlying these properties remain poorly understood, the results obtained turn phlorotannins purified extracts a novel and potent pharmacological alternative for the treatment of a wide range of microbial infections, which usually also present an inflammatory component. In addition to the biological properties demonstrated herein, phlorotannins extracts may also be preferred, in order to avoid side effects and allergic reactions commonly associated with synthetic drugs.
format Online
Article
Text
id pubmed-3271118
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32711182012-02-08 Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions? Lopes, Graciliana Sousa, Carla Silva, Luís R. Pinto, Eugénia Andrade, Paula B. Bernardo, João Mouga, Teresa Valentão, Patrícia PLoS One Research Article Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized for their biological capacity. This study represents the first research on the antibacterial, antifungal, anti-inflammatory and antioxidant activity of phlorotannins purified extracts, which were obtained from ten dominant brown seaweeds of the occidental Portuguese coast. Phlorotannins content was determined by the specific dimethoxybenzaldehyde (DMBA) method and a yield between 75 and 969 mg/Kg phloroglucinol units (dry matter) was obtained. Fucus spiralis ranked first, followed by three Cystoseira species. The anti-inflammatory potential of the purified extracts was assessed via inhibitory effect on nitric oxide (NO) production by lipopolysaccharide-stimulated RAW 264.7 macrophage cells, Cystoseira tamariscifolia being the one showing promising activity for the treatment of inflammation. NO scavenging ability was also addressed in cell free systems, F. spiralis being the species with highest capacity. The antimicrobial potential of the extracts was checked against five Gram-positive and four Gram-negative bacteria and three fungi strains, that commonly colonize skin and mucosa and are responsible for food contamination. The different extracts were more effective against Gram-positive bacteria, Staphylococcus epidermidis being the most susceptible species. Concerning antifungal activity, Trichophyton rubrum was the most sensitive species. Although the molecular mechanisms underlying these properties remain poorly understood, the results obtained turn phlorotannins purified extracts a novel and potent pharmacological alternative for the treatment of a wide range of microbial infections, which usually also present an inflammatory component. In addition to the biological properties demonstrated herein, phlorotannins extracts may also be preferred, in order to avoid side effects and allergic reactions commonly associated with synthetic drugs. Public Library of Science 2012-02-02 /pmc/articles/PMC3271118/ /pubmed/22319609 http://dx.doi.org/10.1371/journal.pone.0031145 Text en Lopes et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lopes, Graciliana
Sousa, Carla
Silva, Luís R.
Pinto, Eugénia
Andrade, Paula B.
Bernardo, João
Mouga, Teresa
Valentão, Patrícia
Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title_full Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title_fullStr Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title_full_unstemmed Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title_short Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?
title_sort can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271118/
https://www.ncbi.nlm.nih.gov/pubmed/22319609
http://dx.doi.org/10.1371/journal.pone.0031145
work_keys_str_mv AT lopesgraciliana canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT sousacarla canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT silvaluisr canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT pintoeugenia canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT andradepaulab canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT bernardojoao canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT mougateresa canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions
AT valentaopatricia canphlorotanninspurifiedextractsconstituteanovelpharmacologicalalternativeformicrobialinfectionswithassociatedinflammatoryconditions